NasdaqCM - Nasdaq Real Time Price USD

eXoZymes, Inc. (EXOZ)

14.48
+1.81
+(14.29%)
As of 3:11:38 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Michael Heltzen President & CEO 271.25k -- 1981
Dr. Tyler Korman Ph.D. Co-Founder & Vice President of Research 245.67k -- 1979
Dr. Paul Opgenorth Ph.D. Co-Founder & Vice President of Development 242.8k -- 1983
Mr. Fouad Nawaz Vice President of Finance 183.75k -- 1986
Mr. James U. Bowie Ph.D. Founder & Independent Director -- -- 1962
Mr. Lasse H. Gorlitz Vice President of Communications -- -- --
Mr. Michael Burns Executive Vice President of Energy Transition -- -- --
Dr. Zachary Karl Ph.D. VP & Head of Business Development -- -- --
Mr. Damien A. Perriman Chief Commercial Officer -- -- 1977

eXoZymes, Inc.

750 Royal Oaks Drive
Suite 106
Monrovia, CA 91016
United States
626 415 1488 https://www.exozymes.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
31

Description

eXoZymes, Inc. a development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application. The company produces chemicals, including pharmaceuticals, fuels, materials, food additives, colors, fragrance and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.

Corporate Governance

eXoZymes, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 10:59 AM UTC

eXoZymes, Inc. Earnings Date

Recent Events

April 25, 2025 at 12:00 AM UTC

S-8: Offering Registrations

April 2, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 31, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 21, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers